Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009974
Filing Date
2019-11-05
Accepted
2019-11-05 16:15:48
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20190930x10q.htm 10-Q 2500792
2 EX-10.1 rigl-20190930ex101a367bb.htm EX-10.1 838066
3 EX-31.1 rigl-20190930ex3114d18e3.htm EX-31.1 17794
4 EX-31.2 rigl-20190930ex3123faba6.htm EX-31.2 17784
5 EX-32.1 rigl-20190930ex321abb861.htm EX-32.1 9429
6 GRAPHIC rigl20190930ex101a367bb001.jpg GRAPHIC 16108
7 GRAPHIC rigl20190930x10q001.jpg GRAPHIC 39354
  Complete submission text file 0001558370-19-009974.txt   8608325

Data Files

Seq Description Document Type Size
8 EX-101.INS rigl-20190930.xml EX-101.INS 1636382
9 EX-101.SCH rigl-20190930.xsd EX-101.SCH 49099
10 EX-101.CAL rigl-20190930_cal.xml EX-101.CAL 51329
11 EX-101.DEF rigl-20190930_def.xml EX-101.DEF 166742
12 EX-101.LAB rigl-20190930_lab.xml EX-101.LAB 425567
13 EX-101.PRE rigl-20190930_pre.xml EX-101.PRE 305467
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 191193479
SIC: 2834 Pharmaceutical Preparations